• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,409.98 254.36
( 0.33%)
Global Indices
Nasdaq
51,515.27 -505.40
(-0.97%)
Dow Jones
7,441.22 -91.13
(-1.21%)
Hang Seng
71,050.31 1,148.06
(1.64%)
Nikkei 225
10,505.62 11.41
(0.11%)
Forex
USD-INR
94.55 -0.09
(-0.09%)
EUR-INR
109.66 -0.13
(-0.12%)
GBP-INR
126.84 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Mercury Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
538964
INE947G01011
484
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
17.59
90.07
EPS(TTM)
Face Value()
Div & Yield %
42.68
10
0.47
 

Sawaca Enterprises reports standalone net loss of Rs 1.06 crore in the March 2026 quarter
May 30,2026
Net Loss of Sawaca Enterprises reported to Rs 1.06 crore in the quarter ended March 2026 as against net loss of Rs 1.74 crore during the previous quarter ended March 2025. Sales rose 28.05% to Rs 12.37 crore in the quarter ended March 2026 as against Rs 9.66 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.41 crore in the year ended March 2026 as against net loss of Rs 0.35 crore during the previous year ended March 2025. Sales declined 53.84% to Rs 37.97 crore in the year ended March 2026 as against Rs 82.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales12.379.66 28 37.9782.25 -54
OPM %-2.91-19.36 --4.00-1.50 -
PBDT-0.73-1.71 57 0.410.25 64
PBT-0.82-1.79 54 0.110.09 22
NP-1.06-1.74 39 -0.41-0.35 -17